HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience

Anselmo, 2002, New era of liver transplantation for hepatitis B: a 17-year single-center experience, Ann Surg, 235, 611, 10.1097/00000658-200205000-00002 Rao, 2009, Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis, Transpl Int, 22, 387, 10.1111/j.1432-2277.2008.00784.x Zoulim, 2003, Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?, J Hepatol, 38, 850, 10.1016/S0168-8278(03)00151-X Fontana, 2001, A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation, Liver Transpl, 7, 504, 10.1053/jlts.2001.24896 Tchervenkov, 2001, Decreasing viral load pretransplant and passive immunoprophylaxis with hepatitis B immunoglobulin posttransplant prevents hepatitis B virus recurrence after liver transplantation: an 8-year single-center experience, Transplant Proc, 33, 1514, 10.1016/S0041-1345(00)02576-8 Lee, 2000, Prophylaxis against hepatitis B recurrence following liver transplantation in HBsAg(+) patients, Transplant Proc, 32, 2248, 10.1016/S0041-1345(00)01786-3 Neff, 2004, Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade, Liver Transpl, 10, 1372, 10.1002/lt.20277 Lee, 2001, Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine, Transplant Proc, 33, 3643, 10.1016/S0041-1345(01)02567-2 Seehofer, 2001, Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation, Liver Transpl, 7, 976, 10.1053/jlts.2001.28442 Mentha, 1997, High-titered anti-HBs fresh frozen plasma for immunoprophylaxis against hepatitis B virus recurrence after liver transplantation, Transplant Proc, 29, 2369, 10.1016/S0041-1345(97)00407-7 Bui Han, 2004, Liver transplantation for hepatitis B, Hepatol Res, 29, 193, 10.1016/j.hepres.2004.02.015 Shaw, 2000, Combination chemotherapy for hepatitis B virus: the path forward?, Drugs, 60, 517, 10.2165/00003495-200060030-00001 Cirera, 2001, Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation, Transplant Proc, 33, 2551, 10.1016/S0041-1345(01)02096-6 Roche, 2003, Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results, J Hepatol, 39, S181, 10.1016/S0168-8278(03)00335-0 Papatheodoridis, 2003, Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era, Am J Transplant, 3, 250, 10.1034/j.1600-6143.2003.00063.x Zoulim, 1998, Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy, J Hepatol, 29, 151, 10.1016/S0168-8278(98)80191-8 Bartholomew, 1997, Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation, Lancet, 349, 20, 10.1016/S0140-6736(96)02266-0 Bárcena, 1999, Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection, Transplant Proc, 31, 2457, 10.1016/S0041-1345(99)00416-9 Han, 2006, Outcomes of hepatitis B virus recurrence after liver transplantation, Transplant Proc, 38, 2123, 10.1016/j.transproceed.2006.06.032 Wong, 2007, Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma, Liver Transpl, 13, 334, 10.1002/lt.20959 Wang, 2004, Prevention of hepatitis B virus reinfection after orthotopic liver transplantation, Transplant Proc, 36, 2315, 10.1016/j.transproceed.2004.07.070